Nolan Capital, founded in 2014, is a family office investment firm focused on long-term growth opportunities in the United States. The company targets control equity investments in industry-leading U.S. companies with proven management teams. Nolan Capital's investment strategy spans various sectors, with a particular interest in growth-oriented businesses.
The firm's portfolio includes notable companies in the biotechnology and gene therapy sectors, such as Encoded Therapeutics, Jaguar Gene Therapy, Palvella Therapeutics, and Taysha Gene Therapies. Nolan Capital participates in various investment rounds, from seed to Series D, demonstrating its commitment to supporting companies at different stages of growth. Founded by Peter Nolan, the firm leverages its expertise to identify and nurture promising investment opportunities.
Nolan Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages